Crunching the numbers for AMGN... Refresh in a moment for the full analysis.
AMGEN INC (AMGN)
Healthcare
Deep Overvalued
healthy
$353.67
Updated: 2026-04-09
61
TradeApes Score
add
Financial Strength
40
Weak
Operating Trend
63
Healthy
Valuation
75
Strong
Capital Allocation
55
Mixed
Risk
80
Strong
Fair Value
$25.01
DCF Upside
-92.9%
Sector Rank
#14
of 18
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
High leverage — net debt/EBITDA between 3× and 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.